Tranexamic Acid in Traumatic Brain Injury

Recruiting now · Phase 3

Conditions studied: Inflammatory Response

In brief

In this study, our aim is to investigate the role of tranexamic acid for modulating the inflammation in patients with traumatic brain injury (TBI).

Key facts

Study ID

NCT05323149

Run by

Assiut University

People needed

60

Starts

2022-05-18

Expected to finish

2027-10-15

Last updated by the study team

2026-01-02

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Isolated traumatic brain injury patients (mild or moderate cases)
• GCS > 8
• non penetrating TBI in 8 hours onset
• Age ≥ 18 years

You may not qualify if…

• Patient in cardiac arrest
• Patients with coagulopathies
• Renal failure patients
• pregnancy
• Patient refusal to participate

Where it is running

• Assiut university hospital — Asyut, Assuit, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.